Early Australian experience with infliximab a chimeric antibody against tumour necrosis factor- in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?

M Mortimore, Peter Raymond Gibson, W S Selby, Graham L Radford-Smith, Timothy H J Florin

Research output: Contribution to journalArticleResearchpeer-review

51 Citations (Scopus)
Original languageEnglish
Pages (from-to)146 - 150
Number of pages5
JournalInternal Medicine Journal
Volume31
Issue number3
Publication statusPublished - 2001

Cite this